178 filings
Page 6 of 9
8-K
r0sbb dac605nllv
5 Feb 19
Regulation FD Disclosure
7:01am
8-K
py832o2od0ka5
18 Jan 19
Departure of Directors or Certain Officers
4:38pm
8-K
0muqr8c4p8qd vmxnj
11 Dec 18
Other Events
9:00am
8-K
853 16ws7ydkq2
5 Dec 18
Changes in Registrant's Certifying Accountant
12:00am
8-K
19hm5 3kkrg8u7asc
20 Nov 18
Departure of Directors or Certain Officers
4:15pm
8-K
gpm86 updiq
13 Nov 18
Aravive Presents Detailed Results of Phase 1 Clinical Trial of AVB-S6-500 at the 2018 EORTC-NCI-AACR Symposium
7:10am
8-K
cr8y56xq8cki0tz
6 Nov 18
Aravive Reports Third Quarter 2018 Financial Results and Provides Company Updates
4:20pm
8-K
h5ogbh kvbb
30 Oct 18
Regulation FD Disclosure
6:16am
8-K
ld78mokeidun3y2 6s
16 Oct 18
Completion of Acquisition or Disposition of Assets
5:05pm
8-K
b77lx wyyak2vi7u
5 Oct 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
vq5uk lbpf
20 Sep 18
Entry into a Material Definitive Agreement
4:24pm
8-K/A
nqnsb7hxp
8 Aug 18
Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent Developments
4:09pm
8-K
h63a0 2xyau9d7pt
7 Aug 18
Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent Developments
12:00am
8-K
qc2buidu
4 Jun 18
Entry into a Material Definitive Agreement
12:00am
8-K
kto xs5w5to
8 May 18
Cost Associated with Exit or Disposal Activities
12:00am
8-K
bbx2pnqp 6x
8 May 18
Versartis Reports First Quarter 2018 Financial Results
12:00am
8-K/A
r6zsmbxgjyhaw8pz3fv
5 Mar 18
Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
12:00am
8-K
nqiud21kk8 1lvn6
1 Mar 18
Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
12:00am
8-K
6syq0p
25 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
tn1irp3
8 Jan 18
Termination of a Material Definitive Agreement
12:00am